MedPath

Study of Effects of Vitamin D on expression of some of genes in MS patient

Not Applicable
Conditions
multiple sclerosis.
Multiple sclerosis
Registration Number
IRCT2014011216181N1
Lead Sponsor
Tarbiat Modares University of Tehrean
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

relapsing-remitting multiple sclerosis patients; MS patients with vitamin D deficiency (<80ng/ml).
Exclusion criteria: patients treated with vitamin D supplements; progressive MS; relapsed patients.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of IL10 gene. Timepoint: before vitamin D treatment and two month after treatment. Method of measurement: obtain of blood from patients and measurment of mRNA level.;Expression of TGF-B1 gene. Timepoint: before vitamin D treatment and two month after treatment. Method of measurement: obtain of blood from patients and measurement of mRNA level.;Expression of TGF-B2, TGF-B receptor I, TGFB receptor II, NF-KB, VDR gene. Timepoint: before vitamin D treatment and two month after treatment. Method of measurement: obtain of blood from patients and measurement of mRNA level.;Serum vitamin D. Timepoint: before vitamin D treatment and two month after treatment. Method of measurement: obtain of blood from patients and measurement of serum vitamin D level.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath